Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma

Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sharon Changshan Wu, Karl Münger
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
HPV
Acceso en línea:https://doaj.org/article/f08826ba092240778bfd49fa7117c566
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f08826ba092240778bfd49fa7117c566
record_format dspace
spelling oai:doaj.org-article:f08826ba092240778bfd49fa7117c5662021-11-25T17:02:41ZRole and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma10.3390/cancers132256902072-6694https://doaj.org/article/f08826ba092240778bfd49fa7117c5662021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5690https://doaj.org/toc/2072-6694Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of studies implicate CT antigens in almost all hallmarks of cancer, suggesting that they may act as cancer drivers. CT antigens are expressed in head and neck squamous cell carcinomas. However, their role in the pathogenesis of these cancers remains poorly studied. Given that CT antigens hold intriguing potential as therapeutic targets and as biomarkers for prognosis and that they can provide novel insights into oncogenic mechanisms, their further study in the context of head and squamous cell carcinoma is warranted.Sharon Changshan WuKarl MüngerMDPI AGarticleCT antigensHNSCCHPVNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5690, p 5690 (2021)
institution DOAJ
collection DOAJ
language EN
topic CT antigens
HNSCC
HPV
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle CT antigens
HNSCC
HPV
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sharon Changshan Wu
Karl Münger
Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
description Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of studies implicate CT antigens in almost all hallmarks of cancer, suggesting that they may act as cancer drivers. CT antigens are expressed in head and neck squamous cell carcinomas. However, their role in the pathogenesis of these cancers remains poorly studied. Given that CT antigens hold intriguing potential as therapeutic targets and as biomarkers for prognosis and that they can provide novel insights into oncogenic mechanisms, their further study in the context of head and squamous cell carcinoma is warranted.
format article
author Sharon Changshan Wu
Karl Münger
author_facet Sharon Changshan Wu
Karl Münger
author_sort Sharon Changshan Wu
title Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
title_short Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
title_full Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
title_fullStr Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
title_full_unstemmed Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
title_sort role and clinical utility of cancer/testis antigens in head and neck squamous cell carcinoma
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f08826ba092240778bfd49fa7117c566
work_keys_str_mv AT sharonchangshanwu roleandclinicalutilityofcancertestisantigensinheadandnecksquamouscellcarcinoma
AT karlmunger roleandclinicalutilityofcancertestisantigensinheadandnecksquamouscellcarcinoma
_version_ 1718412812107120640